Tuesday , 7 May 2024
enfrit
As coming out from jail, Jean Nicol Ramarovahiny decided to restore his reputation. He retaliated by lodging a complain against Christian Zaraniaina for slander. Both figures have a dispute stake of which is the anti-AIDS remedy which proved to be efficient on some patients. This trial might pave Ramarovahiny's way to convince partners to achieve the clinical tests' second phase.

AIDS research: Ramarovahiny strikes back

The court rejected Christian Zaraniaina on July 16th, 2010 and set Jean Nicol Ramarovahiny free. In the end, the latter won this confrontation with his former colleague. The court assessed the accusations and the presented proofs to be out of legal basis. There will consequently be no trial, but Jean Nicol Ramarovahiny would have endured prison sentence anyway. 

 

Just as his adversary Zaraniana did, Ramarovahiny will have to justify the complaint lodged against a former colleague who worked with him as their researches were starting. “My reputation has been seriously damaged”, explained a man who didn’t look too much affected by 5 weeks spent behind bars. According to a searcher, a condemnation of his adversary for slander would restore the status quo. An association struggling against HIV AIDS supported Ramarovahiny’s staff in the development of the JMAR1 remedy. 

Jean Nicol Ramarovahiny’s reputation definitely has to be as clean as possible since the needed funds are quite significant. The clinical tests’ second phase would require between 5 and 8 million US dollars. The project was halted during it’s father’s jail detention. Things are now back on track, only financial support and the Malagasy science committee’s authorization are being expected. The clinical test in question, already authorized by the Health ministry, will be performed on 200 patients to be treated in hospital. “We are lacking of financial and material means to complete this”, argued Jean Nicol Ramarovahiny. 

 

The clinical test’s first stage was encouraging. The JMAR 1 appeared efficient on several cases. It is still too early  to confirm whether the remedy is inhibiting or definitely healing the HIV AIDS virus. The test’s first stage had to be completed in Mauritius because searchers required suited hardware in order to measure the viral progression. Some HIV infected people freely served as volunteers for the test. For the second phase, finding 200 HIV infected volunteers in Madagascar is already problematic.  

 

In 1998, Christian Zaraniana announced his discovery of a remedy against HIV AIDS based on Madagascar’s endemic plants. The research completed by this jurist by profession didn’t match all scientific processes required and consequently had to face up to general skepticism. Everything fell though despite experiments carried on abroad. And Jean Nicol Ramarovahiny now presents the JMAR1 following the training of a new searchers team within the association JC Phytopharmacie. In quality of Zaraniaina’s former apprentice, he kept away from committing the same mistakes. The second research is more believable and the remedy’s efficiency is a fact. After this try, a clinical test with a required 60% success rate, meaning 120 “recoveries” out of 200 HIV infected patients would be the transformation.